• Revenue and earnings at the high-end of Q4 guidance
  • Revenue of $753 million in Q4’24, up 12% from Q4’23
  • Q4 growth driven by strong AI-related demand and improved broader market dynamics

Teradyne, Inc. (NASDAQ:TER):

 

 

Q4'24

 

 

Q4'23

 

 

Q3'24

 

 

FY 2024

 

 

FY 2023

 

Revenue (mil)

 

$

753

 

 

$

671

 

 

$

737

 

 

$

2,820

 

 

$

2,676

 

GAAP EPS

 

$

0.90

 

 

$

0.72

 

 

$

0.89

 

 

$

3.32

 

 

$

2.73

 

Non-GAAP EPS

 

$

0.95

 

 

$

0.79

 

 

$

0.90

 

 

$

3.22

 

 

$

2.93

 

Teradyne, Inc. (NASDAQ: TER) reported revenue of $753 million for the fourth quarter of 2024 of which $561 million was in Semiconductor Test and $98 million in Robotics. GAAP net income for the fourth quarter of 2024 was $146.3 million or $0.90 per diluted share. On a non-GAAP basis, Teradyne’s net income in the fourth quarter of 2024 was $155.0 million, or $0.95 per diluted share, which excluded acquired intangible asset amortization, restructuring and other charges, amortization on our investment in Technoprobe, pension mark-to-market, and included the related tax impact on non-GAAP adjustments.

“Our Q4 results were toward the high end of our guidance range, driven by demand in our Semi Test business. For the quarter, AI compute and related memory remained strong while Mobile and Auto/Industrial exceeded our expectations,” said Teradyne CEO, Greg Smith. “In 2025, we expect year-over-year revenue acceleration with improving conditions in our test businesses. We expect the secular growth opportunities in AI compute and memory to remain, and we will continue to invest into these areas. Additionally, we plan to strategically realign our Robotics business to enhance customer experience and drive operational efficiency. Over the mid-term, we expect that this realignment will support our growth and profitability objectives.”

Guidance for the first quarter of 2025 is revenue of $660 million to $700 million, with GAAP net income of $0.48 to $0.59 per diluted share and non-GAAP net income of $0.58 to $0.68 per diluted share. Non-GAAP guidance excludes acquired intangible asset amortization, amortization on our investment in Technoprobe, restructuring and other costs, as well as the related tax impact on non-GAAP adjustments.

Note that the Semiconductor Test segment revenue includes the results of the Integrated Systems Test ("IST") component, with product lines for system level and hard disk drive testing, that was previously included in our System Test segment results. IST contributed $19 million to Semiconductor Test in the fourth quarter.

Webcast

A conference call to discuss the fourth quarter results, along with management’s business outlook, will follow at 8:30 a.m. ET, Thursday, January 30, 2025. Interested investors should access the webcast at www.teradyne.com and click on "Investors" at least five minutes before the call begins. Presentation materials will be available starting at 8:30 a.m. ET. A replay will be available on the Teradyne website at www.teradyne.com/investors.

Non-GAAP Results

In addition to disclosing results that are determined in accordance with GAAP, Teradyne also discloses non-GAAP results of operations that exclude certain income items and charges. These results are provided as a complement to results provided in accordance with GAAP. Non-GAAP income from operations and non-GAAP net income exclude acquired intangible assets amortization, restructuring and other, pension actuarial gains and losses, stock compensation modification expense, gains and losses on foreign exchange options in connection with acquisitions and divestitures, gain on sale of business, legal settlement, discrete income tax adjustments, and includes the related tax impact on non-GAAP adjustments. GAAP requires that these items be included in determining income from operations and net income. Non-GAAP income from operations, non-GAAP net income, non-GAAP income from operations as a percentage of revenue, non-GAAP net income as a percentage of revenue, and non-GAAP net income per share are non-GAAP performance measures presented to provide meaningful supplemental information regarding Teradyne’s baseline performance before gains, losses or other charges that may not be indicative of Teradyne’s current core business or future outlook. These non-GAAP performance measures are used to make operational decisions, to determine employee compensation, to forecast future operational results, and for comparison with Teradyne’s business plan, historical operating results and the operating results of Teradyne’s competitors. Non-GAAP diluted shares include the impact of Teradyne’s call option on its shares. Management believes each of these non-GAAP performance measures provides useful supplemental information for investors, allowing greater transparency to the information used by management in its operational decision making and in the review of Teradyne’s financial and operational performance, as well as facilitating meaningful comparisons of Teradyne’s results in the current period compared with those in prior and future periods. A reconciliation of each available GAAP to non-GAAP financial measure discussed in this press release is contained in the attached exhibits and on the Teradyne website at www.teradyne.com by clicking on “Investor Relations” and then selecting “Financials” and the “GAAP to Non-GAAP Reconciliation” link. The non-GAAP performance measures discussed in this press release may not be comparable to similarly titled measures used by other companies. The presentation of non-GAAP measures is not meant to be considered in isolation, as a substitute for, or superior to, financial measures or information provided in accordance with GAAP.

About Teradyne

Teradyne (NASDAQ:TER) designs, develops, and manufactures automated test equipment and advanced robotics systems. Its test solutions for semiconductors and electronics products enable Teradyne’s customers to consistently deliver on their quality standards. Its advanced robotics business includes collaborative robots and mobile robots that support manufacturing and warehouse operations for companies of all sizes. For more information, visit teradyne.com. Teradyne® is a registered trademark of Teradyne, Inc., in the U.S. and other countries.

Safe Harbor Statement

This release contains forward-looking statements including statements regarding Teradyne’s future business prospects, financial performance or position and results of operations. You can identify forward-looking statements by their use of forward-looking words such as “anticipate,” “expect,” “plan,” “could,” “may,” “will,” “believe,” “estimate,” “goal” or other comparable terms. Forward-looking statements in this press release address various matters, including statements regarding Teradyne’s financial guidance. Investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements due to known and unknown risks, uncertainties, assumptions, and other factors. Such factors include, but are not limited to, macroeconomic factors and slowdowns or downturns in economic conditions generally and in the markets in which Teradyne operates; decreased or delayed product demand from one or more significant customers; a slowdown or inability in the development, delivery and acceptance of new products; the ability to grow the Robotics business; the impact of increased research and development spending; the impact of epidemics or pandemics such as COVID-19; the impact of a supply shortage on our supply chain and contract manufacturers; the consummation and success of any mergers or acquisitions; unexpected cash needs; the business judgment of the board of directors that a declaration of a dividend or the repurchase of common stock is not in Teradyne’s best interests; changes to U.S. or global tax regulations or guidance; the impact of any tariffs or export controls imposed by the U.S. or China; the impact of U.S. Department of Commerce or other government agency regulations relating to Huawei, HiSilicon and other customers or potential customers; the impact of U.S. Department Commerce export control regulations for certain U.S. products and technology sold to military end users or for military end-use in China; the impact of the current conflicts in Israel; the impact of regulations published by the U.S. Department of Commerce relating to semiconductors and semiconductor manufacturing equipment destined for certain end uses in China.

The risks included above are not exhaustive. For a more detailed description of the risk factors associated with Teradyne, please refer to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023. Many of these factors are macroeconomic in nature and are, therefore, beyond Teradyne’s control. We caution readers not to place undue reliance on any forward-looking statements included in this press release which speak only as to the date of this press release. Teradyne specifically disclaims any obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.

TERADYNE, INC. REPORT FOR FOURTH FISCAL QUARTER OF 2024

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

 

 

Quarter Ended

 

 

Year Ended

 

 

 

December 31, 2024

 

 

September 29, 2024

 

 

December 31, 2023

 

 

December 31, 2024

 

 

December 31, 2023

 

Net revenues

 

$

752,884

 

 

$

737,298

 

 

$

670,600

 

 

$

2,819,880

 

 

$

2,676,298

 

Cost of revenues (exclusive of acquired intangible assets amortization shown separately below) (1)

 

 

305,597

 

 

 

300,784

 

 

 

291,055

 

 

 

1,170,953

 

 

 

1,139,550

 

Gross profit

 

 

447,287

 

 

 

436,514

 

 

 

379,545

 

 

 

1,648,927

 

 

 

1,536,748

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling and administrative (2)

 

 

155,739

 

 

 

157,649

 

 

 

142,336

 

 

 

617,047

 

 

 

577,315

 

Engineering and development

 

 

128,387

 

 

 

117,474

 

 

 

102,207

 

 

 

460,876

 

 

 

418,089

 

Acquired intangible assets amortization

 

 

4,656

 

 

 

4,748

 

 

 

4,651

 

 

 

18,764

 

 

 

18,999

 

Restructuring and other (3)

 

 

4,554

 

 

 

4,578

 

 

 

6,027

 

 

 

15,571

 

 

 

21,277

 

Loss (gain) on sale of business (4)

 

 

367

 

 

 

 

 

 

 

 

 

(57,119

)

 

 

 

Operating expenses

 

 

293,703

 

 

 

284,449

 

 

 

255,221

 

 

 

1,055,139

 

 

 

1,035,680

 

Income from operations

 

 

153,584

 

 

 

152,065

 

 

 

124,324

 

 

 

593,788

 

 

 

501,068

 

Interest and other (income) expense (5)

 

 

(4,213

)

 

 

(6,919

)

 

 

(15,482

)

 

 

(15,298

)

 

 

(24,504

)

Income before income taxes and equity in net earnings of affiliate

 

 

157,797

 

 

 

158,984

 

 

 

139,806

 

 

 

609,086

 

 

 

525,572

 

Income tax provision

 

 

5,408

 

 

 

12,260

 

 

 

22,752

 

 

 

59,503

 

 

 

76,820

 

Income before equity in net earnings of affiliate

 

 

152,389

 

 

 

146,724

 

 

 

117,054

 

 

 

549,583

 

 

 

448,752

 

Equity in net earnings of affiliate

 

 

(6,136

)

 

 

(1,075

)

 

 

 

 

 

(7,211

)

 

 

 

Net income

 

$

146,253

 

 

$

145,649

 

 

$

117,054

 

 

$

542,372

 

 

$

448,752

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.90

 

 

$

0.89

 

 

$

0.77

 

 

$

3.41

 

 

$

2.91

 

Diluted

 

$

0.90

 

 

$

0.89

 

 

$

0.72

 

 

$

3.32

 

 

$

2.73

 

Weighted average common shares - basic

 

 

162,478

 

 

 

163,002

 

 

 

152,812

 

 

 

159,083

 

 

 

154,310

 

Weighted average common shares - diluted (6)

 

 

163,184

 

 

 

164,253

 

 

 

162,106

 

 

 

163,314

 

 

 

164,304

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash dividend declared per common share

 

$

0.12

 

 

$

0.12

 

 

$

0.11

 

 

$

0.48

 

 

$

0.44

 

(1)

 

Cost of revenues includes:

 

 

Quarter Ended

 

 

Year Ended

 

 

 

December 31, 2024

 

 

September 29, 2024

 

 

December 31, 2023

 

 

December 31, 2024

 

 

December 31, 2023

 

Provision for excess and obsolete inventory

 

$

3,406

 

 

$

6,078

 

 

$

5,289

 

 

$

18,921

 

 

$

28,358

 

Legal settlement

 

 

 

 

 

3,600

 

 

 

 

 

 

3,600

 

 

 

 

Sale of previously written down inventory

 

 

(441

)

 

 

(472

)

 

 

(1,115

)

 

 

(2,227

)

 

 

(5,161

)

 

 

$

2,965

 

 

$

9,206

 

 

$

4,174

 

 

$

20,294

 

 

$

23,197

 

(2)

 

For the twelve months ended December 31, 2024, selling and administrative expenses included an equity charge of $1.7 million for the modification of Teradyne executives' retirement agreements. For the twelve months ended December 31, 2023, selling and administrative expenses included an equity charge of $5.9 million for the modification of Teradyne’s retired CEO’s outstanding equity awards in connection with his February 1, 2023, retirement.

(3)

 

Restructuring and other consists of:

 

 

Quarter Ended

 

 

Year Ended

 

 

 

December 31, 2024

 

 

September 29, 2024

 

 

December 31, 2023

 

 

December 31, 2024

 

 

December 31, 2023

 

Lease terminations

 

$

1,284

 

 

$

 

 

$

 

 

$

1,284

 

 

$

 

Employee severance

 

 

378

 

 

 

1,280

 

 

 

2,892

 

 

 

5,234

 

 

 

14,727

 

Acquisition and divestiture related expenses

 

 

 

 

 

 

 

 

3,132

 

 

 

2,214

 

 

 

3,132

 

Contract termination

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,511

 

Other

 

 

2,892

 

 

 

3,298

 

 

 

3

 

 

 

6,840

 

 

 

1,907

 

 

 

$

4,554

 

 

$

4,578

 

 

$

6,027

 

 

$

15,572

 

 

$

21,277

 

(4)

 

On May 27, 2024, Teradyne sold Teradyne's Device Interface Solution ("DIS") business, a component of the Semiconductor Test segment, to Technoprobe S.p.A. ("Technoprobe"), for $85.0 million, net of cash and cash equivalents sold and a working capital adjustment.

(5)

 

Interest and other includes:

 

 

Quarter Ended

 

 

Year Ended

 

 

 

December 31, 2024

 

 

September 29, 2024

 

 

December 31, 2023

 

 

December 31, 2024

 

 

December 31, 2023

 

Pension actuarial losses (gains)

 

$

(1,842

)

 

$

(2,262

)

 

$

2,575

 

 

$

(4,355

)

 

$

2,703

 

Loss (gain) on foreign exchange option

 

 

 

 

 

 

 

 

(7,464

)

 

 

9,765

 

 

 

(7,464

)

(6)

 

Under GAAP, when calculating diluted earnings per share, convertible debt must be assumed to have converted if the effect on EPS would be dilutive. Diluted shares assume the conversion of the convertible debt as the effect would be dilutive. Accordingly, for the quarter ended December 31, 2023, 0.2 million shares have been included in diluted shares. For the twelve months ended December 31, 2023, 0.6 million shares have been included in diluted shares. For the quarters ended September 29, 2024, and December 31, 2023, diluted shares included 0.5 million, and 8.6 million shares, respectively, from the convertible note hedge transaction. For the twelve months ended December 31, 2024, and December 31, 2023, diluted shares included 3.6 million and 8.9 million shares, respectively, from the convertible note hedge transaction.

CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands)

 

 

 

December 31, 2024

 

 

December 31, 2023

 

Assets

 

 

 

 

 

 

Cash and cash equivalents

 

$

553,354

 

 

$

757,571

 

Marketable securities

 

 

46,312

 

 

 

62,154

 

Accounts receivable, net

 

 

471,426

 

 

 

422,124

 

Inventories, net

 

 

298,492

 

 

 

309,974

 

Prepayments

 

 

429,086

 

 

 

548,970

 

Other current assets

 

 

17,727

 

 

 

37,992

 

Current assets held for sale

 

 

 

 

 

23,250

 

Total current assets

 

 

1,816,397

 

 

 

2,162,035

 

Property, plant and equipment, net

 

 

508,171

 

 

 

445,492

 

Operating lease right-of-use assets, net

 

 

70,185

 

 

 

73,417

 

Marketable securities

 

 

124,121

 

 

 

117,434

 

Deferred tax assets

 

 

222,438

 

 

 

175,775

 

Retirement plans assets

 

 

11,994

 

 

 

11,504

 

Equity method investment

 

 

494,494

 

 

 

 

Other assets

 

 

49,620

 

 

 

38,580

 

Acquired intangible assets, net

 

 

15,927

 

 

 

35,404

 

Goodwill

 

 

395,367

 

 

 

415,652

 

Assets held for sale

 

 

 

 

 

11,531

 

Total assets

 

$

3,708,714

 

 

$

3,486,824

 

Liabilities

 

 

 

 

 

 

Accounts payable

 

$

134,792

 

 

$

180,131

 

Accrued employees’ compensation and withholdings

 

 

204,991

 

 

 

191,750

 

Deferred revenue and customer advances

 

 

107,710

 

 

 

99,804

 

Other accrued liabilities

 

 

90,777

 

 

 

114,712

 

Operating lease liabilities

 

 

18,699

 

 

 

17,522

 

Income taxes payable

 

 

67,610

 

 

 

48,653

 

Current liabilities held for sale

 

 

 

 

 

7,379

 

Total current liabilities

 

 

624,579

 

 

 

659,951

 

Retirement plans liabilities

 

 

133,338

 

 

 

132,090

 

Long-term deferred revenue and customer advances

 

 

40,505

 

 

 

37,282

 

Long-term other accrued liabilities

 

 

7,442

 

 

 

19,998

 

Deferred tax liabilities

 

 

1,038

 

 

 

183

 

Long-term operating lease liabilities

 

 

57,922

 

 

 

65,092

 

Long-term income taxes payable

 

 

24,596

 

 

 

44,331

 

Liabilities held for sale

 

 

 

 

 

2,000

 

Total liabilities

 

 

889,420

 

 

 

960,927

 

Shareholders’ equity

 

 

2,819,294

 

 

 

2,525,897

 

Total liabilities and shareholders’ equity

 

$

3,708,714

 

 

$

3,486,824

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands)

 

 

 

Quarter Ended

 

 

Twelve Months Ended

 

 

 

December 31, 2024

 

 

December 31, 2023

 

 

December 31, 2024

 

 

December 31, 2023

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

146,253

 

 

$

117,054

 

 

$

542,372

 

 

$

448,752

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation

 

 

26,497

 

 

 

23,260

 

 

 

100,977

 

 

 

92,118

 

Stock-based compensation

 

 

14,855

 

 

 

12,443

 

 

 

60,122

 

 

 

57,682

 

Equity in net earnings of affiliate

 

 

6,136

 

 

 

 

 

 

7,211

 

 

 

 

Amortization

 

 

4,631

 

 

 

4,685

 

 

 

18,764

 

 

 

18,768

 

Provision for excess and obsolete inventory

 

 

3,406

 

 

 

5,289

 

 

 

18,922

 

 

 

28,358

 

Loss (gain) on sale of business

 

 

367

 

 

 

 

 

 

(57,119

)

 

 

 

Deferred taxes

 

 

(20,099

)

 

 

(13,616

)

 

 

(46,360

)

 

 

(37,642

)

Retirement plan actuarial losses (gains)

 

 

(1,842

)

 

 

2,575

 

 

 

(4,355

)

 

 

2,703

 

Losses (gains) on investments

 

 

(83

)

 

 

(11,756

)

 

 

10,056

 

 

 

(14,915

)

Other

 

 

2,751

 

 

 

(811

)

 

 

(2,290

)

 

 

(955

)

Changes in operating assets and liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

12,607

 

 

 

40,786

 

 

 

(52,659

)

 

 

70,977

 

Inventories

 

 

(2,420

)

 

 

(1,068

)

 

 

8,707

 

 

 

5,327

 

Prepayments and other assets

 

 

58,016

 

 

 

20,881

 

 

 

119,454

 

 

 

(43,101

)

Accounts payable and other liabilities

 

 

9,279

 

 

 

42,783

 

 

 

(54,386

)

 

 

46,782

 

Deferred revenue and customer advances

 

 

8,552

 

 

 

(7,693

)

 

 

12,176

 

 

 

(57,210

)

Retirement plans contributions

 

 

(1,645

)

 

 

(1,794

)

 

 

(5,814

)

 

 

(5,492

)

Income taxes

 

 

15,296

 

 

 

15,762

 

 

 

(3,602

)

 

 

(26,921

)

Net cash provided by operating activities

 

 

282,557

 

 

 

248,780

 

 

 

672,176

 

 

 

585,231

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(57,385

)

 

 

(44,336

)

 

 

(198,095

)

 

 

(159,642

)

Purchases of marketable securities

 

 

(10,700

)

 

 

(24,120

)

 

 

(45,796

)

 

 

(161,906

)

Purchases of investments in businesses

 

 

(5,000

)

 

 

 

 

 

(532,060

)

 

 

 

Issuance of convertible loan

 

 

 

 

 

 

 

 

 

 

 

(5,000

)

Proceeds from maturities of marketable securities

 

 

5,190

 

 

 

13,595

 

 

 

38,353

 

 

 

85,042

 

Proceeds from sales of marketable securities

 

 

436

 

 

 

24,438

 

 

 

24,035

 

 

 

61,401

 

Proceeds from the sale of a business, net of cash and cash equivalents sold

 

 

 

 

 

 

 

 

90,348

 

 

 

 

Proceeds from life insurance

 

 

 

 

 

 

 

 

873

 

 

 

460

 

Net cash used for investing activities

 

 

(67,459

)

 

 

(30,423

)

 

 

(622,342

)

 

 

(179,645

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Repurchase of common stock

 

 

(143,521

)

 

 

(50,749

)

 

 

(198,574

)

 

 

(397,241

)

Dividend payments

 

 

(19,487

)

 

 

(16,797

)

 

 

(76,423

)

 

 

(67,878

)

Payments related to net settlement of employee stock compensation awards

 

 

(267

)

 

 

(202

)

 

 

(14,100

)

 

 

(20,788

)

Payments of borrowings on revolving credit facility

 

 

 

 

 

 

 

 

(185,000

)

 

 

 

Payments of convertible debt principal

 

 

 

 

 

(23,529

)

 

 

 

 

 

(50,264

)

Proceeds from borrowings on revolving credit facility

 

 

 

 

 

 

 

 

185,000

 

 

 

 

Issuance of common stock under stock purchase and stock option plans

 

 

65

 

 

 

175

 

 

 

37,330

 

 

 

34,259

 

Net cash used for financing activities

 

 

(163,210

)

 

 

(91,102

)

 

 

(251,767

)

 

 

(501,912

)

Effects of exchange rate changes on cash and cash equivalents

 

 

(8,570

)

 

 

(6,645

)

 

 

(2,284

)

 

 

(876

)

Increase (decrease) in cash and cash equivalents

 

 

43,318

 

 

 

120,610

 

 

 

(204,217

)

 

 

(97,202

)

Cash and cash equivalents at beginning of period

 

 

510,036

 

 

 

636,961

 

 

 

757,571

 

 

 

854,773

 

Cash and cash equivalents at end of period

 

$

553,354

 

 

$

757,571

 

 

$

553,354

 

 

$

757,571

 

GAAP to Non-GAAP Earnings Reconciliation

(In millions, except per share amounts)

 

 

Quarter Ended

 

 

 

 

 

 

December 31, 2024

 

 

% of Net Revenues

 

 

 

 

 

 

September 29, 2024

 

 

% of Net Revenues

 

 

 

 

 

 

December 31, 2023

 

 

% of Net Revenues

 

 

 

 

 

Net revenues

$

752.9

 

 

 

 

 

 

 

 

 

$

737.3

 

 

 

 

 

 

 

 

 

$

670.6

 

 

 

 

 

 

 

 

Gross profit - GAAP

 

447.3

 

 

 

59.4

%

 

 

 

 

 

 

436.5

 

 

 

59.2

%

 

 

 

 

 

 

379.5

 

 

 

56.6

%

 

 

 

 

Legal settlement (1)

 

 

 

 

 

 

 

 

 

 

 

3.6

 

 

 

0.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit - non-GAAP

 

447.3

 

 

 

59.4

%

 

 

 

 

 

 

440.1

 

 

 

59.7

%

 

 

 

 

 

 

379.5

 

 

 

56.6

%

 

 

 

 

Income from operations - GAAP

 

153.6

 

 

 

20.4

%

 

 

 

 

 

 

152.1

 

 

 

20.6

%

 

 

 

 

 

 

124.3

 

 

 

18.5

%

 

 

 

 

Acquired intangible assets amortization

 

4.7

 

 

 

0.6

%

 

 

 

 

 

 

4.7

 

 

 

0.6

%

 

 

 

 

 

 

4.7

 

 

 

0.7

%

 

 

 

 

Restructuring and other (2)

 

4.6

 

 

 

0.6

%

 

 

 

 

 

 

4.6

 

 

 

0.6

%

 

 

 

 

 

 

6.0

 

 

 

0.9

%

 

 

 

 

Legal settlement (1)

 

 

 

 

 

 

 

 

 

 

 

3.6

 

 

 

0.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss (Gain) on sale of business (3)

 

0.4

 

 

 

0.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from operations - non-GAAP

$

163.2

 

 

 

21.7

%

 

 

 

 

 

$

165.0

 

 

 

22.4

%

 

 

 

 

 

$

135.0

 

 

 

20.1

%

 

 

 

 

 

 

 

 

 

 

 

Net Income per Common Share

 

 

 

 

 

 

 

 

Net Income per Common Share

 

 

 

 

 

 

 

 

Net Income per Common Share

 

 

December 31, 2024

 

 

% of Net Revenues

 

 

Basic

 

 

Diluted

 

 

September 29, 2024

 

 

% of Net Revenues

 

 

Basic

 

 

Diluted

 

 

December 31, 2023

 

 

% of Net Revenues

 

 

Basic

 

 

Diluted

 

Net income - GAAP

$

146.3

 

 

 

19.4

%

 

$

0.90

 

 

$

0.90

 

 

$

145.6

 

 

 

19.7

%

 

$

0.89

 

 

$

0.89

 

 

$

117.1

 

 

 

17.5

%

 

$

0.77

 

 

$

0.72

 

Amortization of equity method investment

 

8.0

 

 

 

1.1

%

 

 

0.05

 

 

 

0.05

 

 

 

2.4

 

 

 

0.3

%

 

 

0.01

 

 

 

0.01

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquired intangible assets amortization

 

4.7

 

 

 

0.6

%

 

 

0.03

 

 

 

0.03

 

 

 

4.7

 

 

 

0.6

%

 

 

0.03

 

 

 

0.03

 

 

 

4.7

 

 

 

0.7

%

 

 

0.03

 

 

 

0.03

 

Restructuring and other (2)

 

4.6

 

 

 

0.6

%

 

 

0.03

 

 

 

0.03

 

 

 

4.6

 

 

 

0.6

%

 

 

0.03

 

 

 

0.03

 

 

 

6.0

 

 

 

0.9

%

 

 

0.04

 

 

 

0.04

 

Loss (gain) on sale of business (3)

 

0.4

 

 

 

0.1

%

 

 

0.00

 

 

 

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Legal settlement (1)

 

 

 

 

 

 

 

 

 

 

 

 

 

3.6

 

 

 

0.5

%

 

 

0.02

 

 

 

0.02

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss (gain) on foreign exchange option

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(7.5

)

 

 

-1.1

%

 

 

 

 

 

(0.05

)

Pension mark-to-market adjustment (4)

 

(1.8

)

 

 

-0.2

%

 

 

(0.01

)

 

 

(0.01

)

 

 

(2.3

)

 

 

-0.3

%

 

 

(0.01

)

 

 

(0.01

)

 

 

2.6

 

 

 

0.4

%

 

 

0.02

 

 

 

0.02

 

Exclude discrete tax adjustments

 

(8.0

)

 

 

-1.1

%

 

 

(0.05

)

 

 

(0.05

)

 

 

(8.9

)

 

 

-1.2

%

 

 

(0.05

)

 

 

(0.05

)

 

 

3.3

 

 

 

0.5

%

 

 

0.02

 

 

 

0.02

 

Non-GAAP tax adjustments

 

0.9

 

 

 

0.1

%

 

 

0.01

 

 

 

0.01

 

 

 

(2.1

)

 

 

-0.3

%

 

 

(0.01

)

 

 

(0.01

)

 

 

1.0

 

 

 

0.1

%

 

 

0.01

 

 

 

0.01

 

Net income - non-GAAP

$

155.0

 

 

 

20.6

%

 

$

0.95

 

 

$

0.95

 

 

$

147.6

 

 

 

20.0

%

 

$

0.91

 

 

$

0.90

 

 

$

127.2

 

 

 

19.0

%

 

$

0.83

 

 

$

0.79

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP and non-GAAP weighted average common shares - basic

 

162.5

 

 

 

 

 

 

 

 

 

 

 

 

163.0

 

 

 

 

 

 

 

 

 

 

 

 

152.8

 

 

 

 

 

 

 

 

 

 

GAAP weighted average common shares - diluted (6)

 

163.2

 

 

 

 

 

 

 

 

 

 

 

 

164.3

 

 

 

 

 

 

 

 

 

 

 

 

162.1

 

 

 

 

 

 

 

 

 

 

Exclude dilutive shares related to convertible note transaction

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.2

)

 

 

 

 

 

 

 

 

 

Non-GAAP weighted average common shares - diluted

 

163.2

 

 

 

 

 

 

 

 

 

 

 

 

164.3

 

 

 

 

 

 

 

 

 

 

 

 

161.9

 

 

 

 

 

 

 

 

 

 

(1)

 

For the quarter ended September 29, 2024, legal settlement includes charges for a settlement following a judgment against the Company for infringement of expired patents.

(2)

 

Restructuring and other consists of:

 

Quarter Ended

 

 

 

 

 

 

 

 

December 31, 2024

 

 

 

 

 

 

 

 

September 29, 2024

 

 

 

 

 

 

 

 

December 31, 2023

 

 

 

 

 

 

 

Lease terminations

$

1.3

 

 

 

 

 

 

 

 

$

 

 

 

 

 

 

 

 

$

 

 

 

 

 

 

 

Employee severance

 

0.4

 

 

 

 

 

 

 

 

 

1.3

 

 

 

 

 

 

 

 

 

2.9

 

 

 

 

 

 

 

Acquisition and divestiture related expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3.1

 

 

 

 

 

 

 

Other

 

2.9

 

 

 

 

 

 

 

 

 

3.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

4.6

 

 

 

 

 

 

 

 

$

4.6

 

 

 

 

 

 

 

 

$

6.0

 

 

 

 

 

 

 

(3)

 

On May 27, 2024, Teradyne sold DIS, a component of the Semiconductor Test segment, to Technoprobe, for $85.0 million, net of cash and cash equivalents sold and a working capital adjustment.

(4)

 

For the quarters ended December 31, 2024, September 29, 2024, and December 31, 2023, adjustments to exclude actuarial gains and losses, respectively, recognized under GAAP in accordance with Teradyne’s mark-to-market pension accounting.

(5)

 

For the quarters ended September 29, 2024, and December 31, 2023, non-GAAP weighted average diluted common shares included 0.5 million and 8.6 million shares, respectively, from the convertible note hedge transaction.

 

Twelve Months Ended

 

 

 

 

 

 

December 31, 2024

 

 

% of Net Revenues

 

 

 

 

 

 

December 31, 2023

 

 

% of Net Revenues

 

 

 

 

 

Net Revenues

$

2,819.9

 

 

 

 

 

 

 

 

 

$

2,676.3

 

 

 

 

 

 

 

 

Gross profit - GAAP

 

1,648.9

 

 

 

58.5

%

 

 

 

 

 

 

1,536.7

 

 

 

57.4

%

 

 

 

 

Legal settlement (1)

 

3.6

 

 

 

0.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit - non-GAAP

 

1,652.5

 

 

 

58.6

%

 

 

 

 

 

 

1,536.7

 

 

 

57.4

%

 

 

 

 

Income from operations - GAAP

 

593.8

 

 

 

21.1

%

 

 

 

 

 

 

501.1

 

 

 

18.7

%

 

 

 

 

Acquired intangible assets amortization

 

18.8

 

 

 

0.7

%

 

 

 

 

 

 

19.0

 

 

 

0.7

%

 

 

 

 

Restructuring and other (2)

 

15.6

 

 

 

0.6

%

 

 

 

 

 

 

21.3

 

 

 

0.8

%

 

 

 

 

Legal settlement (1)

 

3.6

 

 

 

0.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity modification charge (3)

 

1.7

 

 

 

0.1

%

 

 

 

 

 

 

5.9

 

 

 

0.2

%

 

 

 

 

Loss (gain) on sale of business (4)

 

(57.1

)

 

 

-2.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from operations - non-GAAP

$

576.3

 

 

 

20.4

%

 

 

 

 

 

$

547.3

 

 

 

20.4

%

 

 

 

 

 

 

 

 

 

 

 

Net Income per Common Share

 

 

 

 

 

 

 

 

Net Income per Common Share

 

 

December 31, 2024

 

 

% of Net Revenues

 

 

Basic

 

 

Diluted

 

 

December 31, 2023

 

 

% of Net Revenues

 

 

Basic

 

 

Diluted

 

Net income - GAAP

$

542.4

 

 

 

19.2

%

 

$

3.39

 

 

$

3.32

 

 

$

448.8

 

 

 

16.8

%

 

$

2.91

 

 

$

2.73

 

Acquired intangible assets amortization

 

18.8

 

 

 

0.7

%

 

 

0.12

 

 

 

0.11

 

 

 

19.0

 

 

 

0.7

%

 

 

0.12

 

 

 

0.12

 

Restructuring and other (2)

 

15.6

 

 

 

0.6

%

 

 

0.10

 

 

 

0.10

 

 

 

21.8

 

 

 

0.8

%

 

 

0.14

 

 

 

0.13

 

Amortization of equity method investment

 

10.4

 

 

 

0.4

%

 

 

0.07

 

 

 

0.06

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss (gain) on foreign exchange option

 

9.8

 

 

 

0.3

%

 

 

0.06

 

 

 

0.06

 

 

 

(7.5

)

 

 

-0.3

%

 

 

(0.05

)

 

 

(0.05

)

Legal settlement (1)

 

3.6

 

 

 

0.1

%

 

 

0.02

 

 

 

0.02

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity modification charge (3)

 

1.7

 

 

 

0.1

%

 

 

0.01

 

 

 

0.01

 

 

 

5.9

 

 

 

0.2

%

 

 

0.04

 

 

 

0.04

 

Pension mark-to-market adjustment (5)

 

(4.4

)

 

 

-0.2

%

 

 

(0.03

)

 

 

(0.03

)

 

 

2.7

 

 

 

0.1

%

 

 

0.02

 

 

 

0.02

 

Loss (gain) on sale of business (4)

 

(57.1

)

 

 

-2.0

%

 

 

(0.36

)

 

 

(0.35

)

 

 

 

 

 

 

 

 

 

 

 

 

Exclude discrete tax adjustments

 

(8.7

)

 

 

-0.3

%

 

 

(0.05

)

 

 

(0.05

)

 

 

(3.4

)

 

 

-0.1

%

 

 

(0.02

)

 

 

(0.02

)

Non-GAAP tax adjustments

 

(6.9

)

 

 

-0.2

%

 

 

(0.04

)

 

 

(0.04

)

 

 

(7.7

)

 

 

-0.3

%

 

 

(0.05

)

 

 

(0.05

)

Convertible share adjustment (6)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.01

 

Net income - non-GAAP

$

525.1

 

 

 

18.6

%

 

$

3.29

 

 

$

3.22

 

 

$

479.6

 

 

 

17.9

%

 

$

3.11

 

 

$

2.93

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP and non-GAAP weighted average common shares - basic

 

159.8

 

 

 

 

 

 

 

 

 

 

 

 

154.3

 

 

 

 

 

 

 

 

 

 

GAAP weighted average common shares - diluted (6)

 

163.3

 

 

 

 

 

 

 

 

 

 

 

 

164.3

 

 

 

 

 

 

 

 

 

 

Exclude dilutive shares from convertible note

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.6

)

 

 

 

 

 

 

 

 

 

Non-GAAP weighted average common shares - diluted

 

163.3

 

 

 

 

 

 

 

 

 

 

 

 

163.7

 

 

 

 

 

 

 

 

 

 

(1)

 

For the twelve months ended December 31, 2024, a legal settlement includes charges for a settlement following a judgment against the Company for infringement of expired patents.

(2)

 

Restructuring and other consists of:

 

Twelve Months Ended

 

 

 

 

 

 

 

 

December 31, 2024

 

 

 

 

 

 

 

 

December 31, 2023

 

 

 

 

 

 

 

Employee severance

$

5.2

 

 

 

 

 

 

 

 

$

14.8

 

 

 

 

 

 

 

Acquisition and divestiture related expenses

 

2.2

 

 

 

 

 

 

 

 

 

3.1

 

 

 

 

 

 

 

Lease terminations

 

1.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contract termination

 

 

 

 

 

 

 

 

 

 

1.5

 

 

 

 

 

 

 

Other

 

6.8

 

 

 

 

 

 

 

 

 

1.9

 

 

 

 

 

 

 

 

$

15.6

 

 

 

 

 

 

 

 

$

21.3

 

 

 

 

 

 

 

(3)

 

For the twelve months ended December 31, 2024, selling and administrative expenses included an equity charge of $1.7 million for the modification of Teradyne’s executives' retirement agreements. For the twelve months ended December 31, 2023, selling and administrative expenses included an equity charge of $5.9 million for the modification of Teradyne’s retired CEO’s outstanding equity awards in connection with his February 1, 2023, retirement.

(4)

 

On May 27, 2024, Teradyne sold DIS, a component of the Semiconductor Test segment, to Technoprobe, for $85.0 million, net of cash and cash equivalents sold and a working capital adjustment.

(5)

 

For twelve months ended December 31, 2024, and December 31, 2023, adjustments to exclude actuarial gains and losses, respectively, recognized under GAAP in accordance with Teradyne’s mark-to-market pension accounting.

(6)

 

For the twelve months ended December 31, 2024 and December 31, 2023, non-GAAP weighted average diluted common shares included 3.6 million and 8.9 million shares, respectively, from the convertible note hedge transaction.

GAAP to Non-GAAP Reconciliation of First Quarter 2025 guidance:

GAAP and non-GAAP first quarter revenue guidance:

 

 

$660 million

 

to

$700 million

 

 

 

 

 

 

 

GAAP net income per diluted share

 

 

$

0.48

 

 

$

0.59

 

 

 

 

 

 

 

Exclude acquired intangible assets amortization

 

 

 

0.03

 

 

 

0.03

 

 

 

 

 

 

 

Exclude restructuring and other charges

 

 

 

0.03

 

 

 

0.03

 

 

 

 

 

 

 

Exclude equity method investment amortization

 

 

 

0.05

 

 

 

0.05

 

 

 

 

 

 

 

Non-GAAP tax adjustments

 

 

 

(0.01

)

 

 

(0.01

)

 

 

 

 

 

 

Non-GAAP net income per diluted share

 

 

$

0.58

 

 

$

0.68

 

 

 

 

 

 

 

For press releases and other information of interest to investors, please visit Teradyne’s homepage at http://www.teradyne.com.

Teradyne, Inc. Traci Tsuchiguchi 978-370-2444 Vice President of Corporate Relations

Teradyne (NASDAQ:TER)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Teradyne Charts.
Teradyne (NASDAQ:TER)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Teradyne Charts.